These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31271700)

  • 1. Elevated thrombin generation in patients with congenital disorder of glycosylation and combined coagulation factor deficiencies.
    Pascreau T; de la Morena-Barrio ME; Lasne D; Serrano M; Bianchini E; Kossorotoff M; Boddaert N; Bruneel A; Seta N; Vicente V; de Lonlay P; Corral J; Borgel D
    J Thromb Haemost; 2019 Nov; 17(11):1798-1807. PubMed ID: 31271700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum of changes in endogenous thrombin potential due to heritable disorders of coagulation.
    Ghosh K; Mota L; Shetty S; Kulkarni B
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):577-80. PubMed ID: 18685441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of thrombin generation assay with conventional coagulation tests in evaluation of bleeding risk in patients with rare bleeding disorders.
    Zekavat OR; Haghpanah S; Dehghani J; Afrasiabi A; Peyvandi F; Karimi M
    Clin Appl Thromb Hemost; 2014 Sep; 20(6):637-44. PubMed ID: 23393288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of thrombin generation platforms for patients with coagulation factor deficiencies: A comprehensive assessment.
    Haisma B; Schols SEM; van Oerle RGM; Verbeek-Knobbe K; Hellenbrand D; Verwoerd EJ; Heubel-Moenen FCJI; Stroobants AK; Meijer D; Rijpma SR; Henskens YMC
    Thromb Res; 2024 Aug; 240():109045. PubMed ID: 38834002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thrombin generation assays and their clinical application].
    Kern A; Várnai K; Vásárhelyi B
    Orv Hetil; 2014 Jun; 155(22):851-7. PubMed ID: 24860049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation disorders and inhibitors of coagulation in children from Mansoura, Egypt.
    Abdelrazik N; Rashad H; Selim T; Tharwat L
    Hematology; 2007 Aug; 12(4):309-14. PubMed ID: 17654057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of coagulation factors and tissue factor concentration on the thrombin generation test in plasma.
    Duchemin J; Pan-Petesch B; Arnaud B; Blouch MT; Abgrall JF
    Thromb Haemost; 2008 Apr; 99(4):767-73. PubMed ID: 18392335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paradoxical bleeding and thrombotic episodes of dysprothrombinaemia due to a homozygous Arg382His mutation.
    Ding Q; Yang L; Zhao X; Wu W; Wang X; Rezaie AR
    Thromb Haemost; 2017 Feb; 117(3):479-490. PubMed ID: 27975099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombin generation testing in routine clinical practice: are we there yet?
    van Veen JJ; Gatt A; Makris M
    Br J Haematol; 2008 Sep; 142(6):889-903. PubMed ID: 18564356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High coagulation factor levels and low protein C levels contribute to enhanced thrombin generation in patients with diabetes who do not have macrovascular complications.
    Kim HK; Kim JE; Park SH; Kim YI; Nam-Goong IS; Kim ES
    J Diabetes Complications; 2014; 28(3):365-9. PubMed ID: 24560421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests.
    Lisman T; Bakhtiari K; Pereboom IT; Hendriks HG; Meijers JC; Porte RJ
    J Hepatol; 2010 Mar; 52(3):355-61. PubMed ID: 20132999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombin generation as an intermediate phenotype for venous thrombosis.
    Segers O; van Oerle Rv; ten Cate Ht; Rosing J; Castoldi E
    Thromb Haemost; 2010 Jan; 103(1):114-22. PubMed ID: 20062924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procoagulant Imbalance in Klinefelter Syndrome Assessed by Thrombin Generation Assay and Whole-Blood Thromboelastometry.
    Indirli R; Ferrante E; Scalambrino E; Profka E; Clerici M; Lettera T; Serban AL; Vena W; Pizzocaro A; Bonomi M; Cangiano B; Carosi G; Mazziotti G; Persani L; Lania A; Arosio M; Peyvandi F; Mantovani G; Tripodi A
    J Clin Endocrinol Metab; 2021 Mar; 106(4):e1660-e1672. PubMed ID: 33382882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin generation reveals high procoagulant potential in the plasma of sickle cell disease children.
    Noubouossie DF; Lê PQ; Corazza F; Debaugnies F; Rozen L; Ferster A; Demulder A
    Am J Hematol; 2012 Feb; 87(2):145-9. PubMed ID: 22052675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A hereditary bleeding disorder resulting from a premature stop codon in thrombomodulin (p.Cys537Stop).
    Langdown J; Luddington RJ; Huntington JA; Baglin TP
    Blood; 2014 Sep; 124(12):1951-6. PubMed ID: 25049278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of haemostasis in patients with cirrhosis: Relevance of the ROTEM tests?: A prospective, cross-sectional study.
    Lentschener C; Flaujac C; Ibrahim F; Gouin-Thibault I; Bazin M; Sogni P; Samama CM
    Eur J Anaesthesiol; 2016 Feb; 33(2):126-33. PubMed ID: 26258657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel congenital dysprothrombinemia leading to defective prothrombin maturation.
    Bafunno V; Bury L; Tiscia GL; Fierro T; Favuzzi G; Caliandro R; Sessa F; Grandone E; Margaglione M; Gresele P
    Thromb Res; 2014 Nov; 134(5):1135-41. PubMed ID: 25242243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemostatic balance between pro- and anticoagulant is maintained during glucocorticoid treatment.
    Yamashita A; Nagae C; Umezawa Y; Mori M; Ashikaga T; Akita M; Suzuki N; Yamazaki S; Takayama S; Taki M
    Pediatr Blood Cancer; 2024 Mar; 71(3):e30812. PubMed ID: 38078567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The thrombogram in rare inherited coagulation disorders: its relation to clinical bleeding.
    Al Dieri R; Peyvandi F; Santagostino E; Giansily M; Mannucci PM; Schved JF; Béguin S; Hemker HC
    Thromb Haemost; 2002 Oct; 88(4):576-82. PubMed ID: 12362226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of patients with unclassified bleeding disorder and abnormal thrombin generation for physiological coagulation inhibitors reveals multiple abnormalities and a subset of patients with increased tissue factor pathway inhibitor activity.
    MacDonald S; White D; Langdown J; Downes K; Thomas W
    Int J Lab Hematol; 2020 Jun; 42(3):246-255. PubMed ID: 32003946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.